Brazil Cancer Immunotherapy Market Size & Outlook, 2026-2033
Related Markets
Brazil cancer immunotherapy market highlights
- The Brazil cancer immunotherapy market generated a revenue of USD 6,065.7 million in 2025 and is expected to reach USD 10,958.9 million by 2033.
- The Brazil market is expected to grow at a CAGR of 7.7% from 2026 to 2033.
- In terms of segment, monoclonal antibodies was the largest revenue generating product in 2025.
- Oncolytic Viral Therapies and Cancer Vaccines is the most lucrative product segment registering the fastest growth during the forecast period.
Cancer immunotherapy market data book summary
| Market revenue in 2025 | USD 6,065.7 million |
| Market revenue in 2033 | USD 10,958.9 million |
| Growth rate | 7.7% (CAGR from 2026 to 2033) |
| Largest segment | Monoclonal antibodies |
| Fastest growing segment | Oncolytic Viral Therapies and Cancer Vaccines |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Monoclonal Antibodies, Check Point Inhibitors, Oncolytic Viral Therapies and Cancer Vaccines |
| Key market players worldwide | Pfizer Inc, AstraZeneca PLC, Merck & Co Inc, Roche Holding AG, Bristol-Myers Squibb Co, Novartis AG ADR, Eli Lilly and Co, Johnson & Johnson, Immunocore Holdings PLC ADR |
Other key industry trends
- In terms of revenue, Brazil accounted for 4.0% of the global cancer immunotherapy market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Latin America, Brazil cancer immunotherapy market is projected to lead the regional market in terms of revenue in 2033.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 2,100.0 million by 2033.
Monoclonal antibodies was the largest segment with a revenue share of 66.16% in 2025. Horizon Databook has segmented the Brazil cancer immunotherapy market based on monoclonal antibodies, check point inhibitors, oncolytic viral therapies and cancer vaccines covering the revenue growth of each sub-segment from 2021 to 2033.
Cancer remains the second leading cause of mortality in Brazil as of 2019. Immunotherapy has revolutionized the cancer treatment paradigm in Brazil, where the disease burden continues to grow at a steady pace.
Although the availability and accessibility of cost-effective oncologic immunotherapeutic drugs are likely to drive the market growth, factors such as gaps in the Brazilian healthcare system, unmet healthcare needs, and financial constraints may restrain market growth. Combinatorial immunotherapeutic approaches are gaining rapid momentum in the Brazilian cancer market.
In order to combat the high price of immunooncology drugs, some of the initiatives implemented in Brazil include CONITEC, petitioned by the Brazilian Society of Clinical Oncology, to determine the aptness of a pharmaceutical agent into the public healthcare system, leading to increased drug accessibility.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Immunotherapy Market Scope
Cancer Immunotherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Immunocore Holdings PLC ADR | View profile | 497 | 92 Park Drive, Milton Park, Abingdon, Oxfordshire, United Kingdom, OX14 4RY | https://www.immunocore.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Brazil cancer immunotherapy market size, by product, 2021-2033 (US$M)
Brazil Cancer Immunotherapy Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
